TG Therapeutics, Inc. (LON:0VGI)

TG Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jan 30, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	3,506	1,897	1,315	1,837	4,909	822
Market Cap Growth	158.88%	44.26%	-28.44%	-62.57%	497.08%	232.84%
Enterprise Value	3,437	1,803	1,237	1,595	4,754	797
Last Close Price	25.72	13.50	9.48	14.37	37.86	5.31
PE Ratio	-	190.66	-	-	-	-
PS Ratio	12.67	10.34	568.84	371.96	44096.70	7164.19
PB Ratio	17.46	15.05	27.04	10.49	12.91	28.20
P/TBV Ratio	17.46	15.13	27.41	10.53	12.93	28.80
EV/Sales Ratio	16.41	9.83	535.23	322.82	42698.06	6947.94
EV/EBITDA Ratio	-	110.20	-	-	-	-
EV/EBIT Ratio	-	111.33	-	-	-	-
Debt / Equity Ratio	1.32	0.69	1.42	0.33	0.08	1.06
Debt / EBITDA Ratio	136.31	4.82	-	-	-	-
Asset Turnover	0.58	0.89	0.01	0.01	0.00	0.00
Quick Ratio	3.65	5.00	3.04	4.84	6.91	1.66
Current Ratio	4.59	5.92	3.16	5.06	6.99	1.77
Return on Equity (ROE)	-8.05%	11.57%	-134.13%	-92.03%	-100.14%	-551.85%
Return on Assets (ROA)	-0.07%	4.93%	-42.05%	-42.87%	-43.36%	-85.68%
Return on Capital (ROIC)	-0.09%	6.24%	-52.58%	-49.04%	-53.28%	-203.76%
Return on Capital Employed (ROCE)	-	7.48%	-	-	-	-
Earnings Yield	-0.31%	0.52%	-12.52%	-13.99%	-4.17%	-15.87%
FCF Yield	-0.60%	-1.30%	-11.12%	-11.90%	-3.21%	-12.21%
Buyback Yield / Dilution	-3.08%	-9.67%	-2.41%	-14.64%	-30.51%	-17.10%
Total Shareholder Return	-3.08%	-9.67%	-2.41%	-14.64%	-30.51%	-17.10%

Source: S&P Capital IQ. Standard template. Financial Sources.